Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 573 (1-2), 168-179
- https://doi.org/10.1016/j.mrfmmm.2004.07.024
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Frequency ofBRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer, 2000
- Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.Journal of Clinical Oncology, 1998
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2Nature, 1997
- Association of BRCA1 with Rad51 in Mitotic and Meiotic CellsCell, 1997
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994